{"calculatePct":false,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"}]}],"title":"Day 28"},{"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"}]}],"title":"Day 56"},{"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"}]}],"title":"Day 180"}],"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"}],"units":"Participants"}],"description":"To assess the proportion of patients developing grade I-IV acute GvHD by Day 28, 56, and 180 post DLI.","groups":[{"description":"Patients who did not move forward to DLI","id":"OG000","title":"Transplant Only"},{"description":"Proceeded to DLI per protocol","id":"OG001","title":"Transplat Plus DLI"}],"paramType":"COUNT_OF_PARTICIPANTS","populationDescription":"all patients who received DLI","reportingStatus":"POSTED","timeFrame":"Day 28, 56, and 180 post DLI.","title":"To Assess the Proportion of Patients Developing Grade I-IV Acute GvHD","type":"SECONDARY","unitOfMeasure":"Participants"}